Tag: Coumadin

Blood Thinners and the Genetics Behind Drug Response

A study in the journal Lancet regarding a new blood thinning drug brings to mind the difficulty doctors and patients have in using anticoagulants to prevent clots that could otherwise lead to heart attacks or strokes. The mostly commonly used blood thinner, warfarin (Coumadin®) has proven to be a godsend ...

Read more

FDA Updates Label for Commonly Used Blood Thinner to Include Dosing Recommendations Based on Genetics

Warfarin (Coumadin®) is a blood thinner given to people at high risk for the formation of blood clots due to conditions such as deep vein thrombosis, heart valve disease or replacement, and irregular heart beat. The drug is also given to prevent recurrence of pulmonary embolism, heart attack and stroke. If ...

Read more

New Study Shows That Genetic Information Can Improve Administration Of Commonly Used Blood Thinner

Each time a doctor writes a prescription for warfarin (Coumadin®), a blood thinner given to about two million people each year in the United States, it’s a guessing game.  There is no “right” dose of the drug.  Everyone is different and it can take weeks of adjustment to find a patient’s ideal amount of the ...

Read more

Return to top